Skip to main content

and
  1. Article

    Open Access

    Viral modulation of type II interferon increases T cell adhesion and virus spread

    During primary varicella zoster virus (VZV) infection, infected lymphocytes drive primary viremia, causing systemic dissemination throughout the host, including the skin. This results in cytokine expression, i...

    Carina Jacobsen, Nina Plückebaum, George Ssebyatika, Sarah Beyer in Nature Communications (2024)

  2. Article

    Open Access

    Standardized generation of human iPSC-derived hematopoietic organoids and macrophages utilizing a benchtop bioreactor platform under fully defined conditions

    There is a significant demand for intermediate-scale bioreactors in academic and industrial institutions to produce cells for various applications in drug screening and/or cell therapy. However, the applicatio...

    Mania Ackermann, Fawaz Saleh, Shifaa M. Abdin in Stem Cell Research & Therapy (2024)

  3. No Access

    Article

    CAR macrophages on a fast track to solid tumor therapy

    Expressing chimeric antigen receptors (CARs) in macrophages has led to promising results in preclinical and clinical work. Now, induced pluripotent stem cells have been combined with a second-generation CAR to...

    Shifaa M. Abdin, Daniela Paasch, Nico Lachmann in Nature Immunology (2024)

  4. No Access

    Protocol

    Adaptation of Human iPSC-Derived Macrophages Toward an Alveolar Macrophage-Like Phenotype Post-Intra-Pulmonary Transfer into Murine Models

    Alveolar macrophages (AMs) represent crucial immune cells in the bronchioalveolar space of the . Given the important role in the host defense machinery and tissue homeostasis, AMs have been linked to a vari...

    Miriam Hetzel, Ingrid Gensch, Mania Ackermann, Nico Lachmann in Tissue-Resident Macrophages (2024)

  5. Article

    Open Access

    An evaluation of an open access iPSC training course: “How to model interstitial lung disease using patient-derived iPSCs”

    Interstitial lung diseases (ILD) are a group of rare lung diseases with severe outcomes. The COST Innovator Grant aims to establish a first-of-a-kind open-access Biorepository of patient-derived induced plurip...

    Anja Schweikert, Sarah Kenny, Irene Oglesby, Arlene Glasgow in Stem Cell Research & Therapy (2023)

  6. No Access

    Article

    Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors

    Macrophages derived from human induced pluripotent stem cells (iPSCs) have the potential to enable the development of cell-based therapies for numerous disease conditions. We here provide a detailed protocol f...

    Mania Ackermann, Anna Rafiei Hashtchin, Felix Manstein in Nature Protocols (2022)

  7. No Access

    Protocol

    Generation of Human iPSC from Small Volume Peripheral Blood Samples

    The generation of induced pluripotent stem cells (iPSCs) from patients has opened new doors to gain insights into disease pathophysiology and treatment. In particular, the generation of iPSCs from patients who...

    Doreen Kloos, Nico Lachmann in Stem Cell Assays (2022)

  8. No Access

    Chapter

    Pulmonale Alveolarproteinose

    Die Alveolarproteinose ist eine sehr seltene Erkrankung mit Akkumulation von Surfactant-Proteinen und Phospholipiden in den Alveolen. Die primäre autoimmune PAP ist die häufigste Form und ist mit Nachweis von ...

    Francesco Bonella, Nico Lachmann, Michael Kreuter in Seltene Lungenerkrankungen (2022)

  9. Article

    Open Access

    From macrophage biology to macrophage-based cellular immunotherapies

    Elvira Mass, Nico Lachmann in Gene Therapy (2021)

  10. Article

    Open Access

    Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo

    Inherited deficiency of the antiprotease alpha-1 antitrypsin (AAT) is associated with liver failure and early-onset emphysema. In mice, in vivo lentiviral transduction of alveolar macrophages (AMs) has been de...

    Ewa Janosz, Miriam Hetzel, Hanna Spielmann, Srinu Tumpara in Gene Therapy (2021)

  11. Article

    Open Access

    Makrophagen in der Krankheitsentstehung und Therapie

    Macrophages are unique cells of the innate immunity and can be found in various tissues (tissue resident macrophages; TRMs). Macrophages and TRMs play a pivotal role in tissue homeostasis and can contribute to...

    Nico Lachmann in BIOspektrum (2021)

  12. No Access

    Article

    Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells

    Induced pluripotent stem cells (iPSCs) from patients with genetic disorders are a valuable source for in vitro disease models, which enable drug testing and validation of gene and cell therapies. We generated ...

    Dirk Hoffmann, Johannes Kuehle, Daniela Lenz, Friederike Philipp in Gene Therapy (2020)

  13. Article

    Open Access

    Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

    The increasing number of severe infections with multi-drug-resistant pathogens worldwide highlights the need for alternative treatment options. Given the pivotal role of phagocytes and especially alveolar macr...

    Mania Ackermann, Henning Kempf, Miriam Hetzel, Christina Hesse in Nature Communications (2018)

  14. Article

    Open Access

    An immune cell spray (ICS) formulation allows for the delivery of functional monocyte/macrophages

    Macrophages are key cells of the innate immune system and act as tissue resident macrophages (TRMs) in the homeostasis of various tissues. Given their unique functions and therapeutic use as well as the feasib...

    Valerie Beneke, Fennja Küster, Anna-Lena Neehus, Christina Hesse in Scientific Reports (2018)

  15. Article

    Open Access

    TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis

    Hereditary pulmonary alveolar proteinosis (herPAP) constitutes a rare, life threatening lung disease characterized by the inability of alveolar macrophages to clear the alveolar airspaces from surfactant phosp...

    Alexandra Kuhn, Mania Ackermann, Claudio Mussolino, Toni Cathomen in Scientific Reports (2017)

  16. Article

    Open Access

    The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function

    Suppression of therapeutic transgene expression from retroviral gene therapy vectors by epigenetic defence mechanisms represents a problem that is particularly encountered in pluripotent stem cells (PSCs) and ...

    Jessica Kunkiel, Natascha Gödecke, Mania Ackermann, Dirk Hoffmann in Scientific Reports (2017)

  17. No Access

    Article

    Lung surfactant metabolism: early in life, early in disease and target in cell therapy

    Lung surfactant is a complex mixture of lipids and proteins lining the alveolar epithelium. At the air–liquid interface, surfactant lowers surface tension, avoiding alveolar collapse and reducing the work of b...

    Elena Lopez-Rodriguez, Gemma Gay-Jordi, Adele Mucci in Cell and Tissue Research (2017)

  18. Article

    Open Access

    Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions

    Platelet (PLT) transfusion is indispensable to maintain homeostasis in thrombocytopenic patients. However, PLT transfusion refractoriness is a common life-threatening condition observed in multitransfused pati...

    Ann-Kathrin Börger, Dorothee Eicke, Christina Wolf, Christiane Gras in Molecular Medicine (2016)

  19. Article

    Open Access

    Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1)

    Hematologic toxicity represents a major side effect of cytotoxic chemotherapy frequently preventing adequately dosed chemotherapy application and impeding therapeutic success. Transgenic (over)expression of ch...

    Sebastian Brennig, Nico Lachmann in Journal of Experimental & Clinical Cancer … (2015)

  20. No Access

    Article

    Pulmonary macrophage transplantation therapy

    Bone-marrow transplantation is an effective cell therapy but requires myeloablation, which increases infection risk and mortality. Recent lineage-tracing studies documenting that resident macrophage population...

    Takuji Suzuki, Paritha Arumugam, Takuro Sakagami, Nico Lachmann, Claudia Chalk in Nature (2014)